Koh, Cho Yeow http://orcid.org/0000-0003-0002-4603
Shih, Norrapat
Yip, Christina Y. C.
Li, Aaron Wei Liang http://orcid.org/0000-0002-7587-1420
Chen, Weiming
Amran, Fathiah S.
Leong, Esther Jia En
Iyer, Janaki Krishnamoorthy
Croft, Grace
Mazlan, Muhammad Ibrahim Bin
Chee, Yen-Lin
Yap, Eng-Soo
Monroe, Dougald M.
Hoffman, Maureane http://orcid.org/0000-0001-7123-0100
Becker, Richard C.
de Kleijn, Dominique P. V.
Verma, Vaishali http://orcid.org/0000-0001-5076-7435
Gupta, Amita
Chaudhary, Vijay K.
Richards, A. Mark
Kini, R. Manjunatha http://orcid.org/0000-0002-6100-3251
Chan, Mark Y. http://orcid.org/0000-0003-0389-7450
Funding for this research was provided by:
MOH | National Medical Research Council (Young Investigator Research Grant (16may021), CIRG17may014)
Article History
Received: 25 January 2021
Accepted: 28 October 2021
First Online: 25 November 2021
Competing interests
: Part of the work related to the peptides as thrombin inhibitors was included in the patent application with C.Y.K., J.K.I. and R.M.K. among the inventors (WO2016204696A1 Novel thrombin inhibitors). Antibodies tested as reversal agents for ultravariegin were included in another patent application with C.Y.K., V.V., A.G., V.K.C., R.M.K. and M.Y.C. among the inventors (application in progress). The remaining authors declare no competing interests.